While most kids on antidepressant drugs get some follow-up care, only 3 percent of the thousands of Minnesota teenagers taking them get as many face-to-face appointments as they should, according to an analysis by the Minnesota Council of Health Plans.
Four years ago, the federal government warned doctors to check frequently on adolescent patients who take antidepressants.
It was all part of a black-box warning issued by the federal Food and Drug Administration (FDA) to reduce the risk of suicidal behavior among the growing number of teenagers who take drugs such as Zoloft and Prozac.
But in Minnesota, the FDA's warning doesn't seem to be working.
"We're just scratching the surface for what ought to be done for adolescent depression," said Dr. David Aughey, director of adolescent medicine for Children's Hospitals and Clinics.
Doctors and other experts say it's likely that doctors, patients and parents are all part of the problem.
Adolescent psychiatrists are scarce and over-subscribed with patients.
Primary care physicians, who do most of the prescribing, are busy, may not know exactly what is expected of them, or could be reluctant to prescribe the drugs. Parents rely on doctors for guidance and can't always afford increasingly larger co-pays. And teenagers, well, are teenagers.